PT Bank Danamon Indonesia Tbk (BDMN):企業の財務・戦略的SWOT分析

◆英語タイトル:PT Bank Danamon Indonesia Tbk (BDMN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12679
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インドネシア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

PT Bank Danamon Indonesia Tbk (BDMN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PT Bank Danamon Indonesia Tbk (Danamon) is a provider of banking products and services. The bank provides personal and business banking services to customers of various segments such as consumer, wholesale, micro, financial institutions and small and medium enterprises. Its personal banking solutions include deposits, savings, loans, debit and credit card, insurance, and investment services. The bank’s offerings include trade finance, asset based financing, cash management, treasury management, current and savings account and financial supply chain as well as syariah banking. In addition, the bank through its subsidiaries Adira Finance and Adira Kredit provides financing for automotive and consumer goods. It also provides digital banking services such SMS banking, mobile banking and internet banking. The bank offers its services through a network of branches, ATMs and service outlets. Danamon is headquartered in Jakarta, Indonesia.

PT Bank Danamon Indonesia Tbk Key Recent Developments

Aug 01,2018: Chandra Asri Petrochemical Signs US$120 million working capital facility agreements with Bank Mandiri
Apr 20,2018: Bank Danamon reports Q1 2018 financial results
Feb 13,2018: Bank Danamon releases full year 2017 financial results
Oct 30,2017: Danamon announces 21% NPAT growth in the first nine months of 2017
Jul 25,2017: PT Bank Danamon H1 profit up

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
PT Bank Danamon Indonesia Tbk – Key Facts 5
PT Bank Danamon Indonesia Tbk – Key Employees 6
PT Bank Danamon Indonesia Tbk – Key Employee Biographies 7
PT Bank Danamon Indonesia Tbk – Major Products and Services 8
PT Bank Danamon Indonesia Tbk – History 9
PT Bank Danamon Indonesia Tbk – Company Statement 12
PT Bank Danamon Indonesia Tbk – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 16
Company Overview 16
PT Bank Danamon Indonesia Tbk – Business Description 17
Business Segment: Mid-Size 17
Overview 17
Performance 17
Business Segment: Retail 17
Overview 17
Performance 17
Business Segment: Wholesale 18
Overview 18
Performance 18
PT Bank Danamon Indonesia Tbk – Corporate Strategy 19
PT Bank Danamon Indonesia Tbk – SWOT Analysis 20
SWOT Analysis – Overview 20
PT Bank Danamon Indonesia Tbk – Strengths 20
PT Bank Danamon Indonesia Tbk – Weaknesses 21
PT Bank Danamon Indonesia Tbk – Opportunities 22
PT Bank Danamon Indonesia Tbk – Threats 23
PT Bank Danamon Indonesia Tbk – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Recent Developments 31
Aug 01, 2018: Chandra Asri Petrochemical Signs US$120 million working capital facility agreements with Bank Mandiri 31
Oct 30, 2017: Danamon announces 21% NPAT growth in the first nine months of 2017 32
Jul 25, 2017: PT Bank Danamon H1 profit up 33
Apr 26, 2017: PT Bank Danamon Indonesia Q1 net income increases 34
Section 5 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
PT Bank Danamon Indonesia Tbk, Key Facts 5
PT Bank Danamon Indonesia Tbk, Key Employees 6
PT Bank Danamon Indonesia Tbk, Key Employee Biographies 7
PT Bank Danamon Indonesia Tbk, Major Products and Services 8
PT Bank Danamon Indonesia Tbk, History 9
PT Bank Danamon Indonesia Tbk, Other Locations 14
PT Bank Danamon Indonesia Tbk, Subsidiaries 15
PT Bank Danamon Indonesia Tbk, Key Competitors 24
PT Bank Danamon Indonesia Tbk, Ratios based on current share price 25
PT Bank Danamon Indonesia Tbk, Annual Ratios 26
PT Bank Danamon Indonesia Tbk, Annual Ratios (Cont...1) 27
PT Bank Danamon Indonesia Tbk, Interim Ratios 29
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
PT Bank Danamon Indonesia Tbk, Performance Chart (2013 - 2017) 28
PT Bank Danamon Indonesia Tbk, Ratio Charts 30

★海外企業調査レポート[PT Bank Danamon Indonesia Tbk (BDMN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • I-Sens Inc (099190):製品パイプライン分析
    Summary I-Sens Inc (i-SENS) is a medical device company that develops and distributes blood glucose monitoring systems. The company’s products comprise blood glucose monitoring systems, electrolyte and gas analyzers, immuno sensors and accessories, among others. It provides blood monitoring systems …
  • World Fuel Services Corporation:企業の戦略・SWOT・財務情報
    World Fuel Services Corporation - Strategy, SWOT and Corporate Finance Report Summary World Fuel Services Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • China National Chemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Chemical Corp (ChemChina) is a state-owned enterprise that develops and markets chemicals. The company offers chemical materials and specialty chemicals, agrochemicals, oil processing and refining products, basic chemicals, and rubber products. ChemChina also manufactures equi …
  • Stater Bros. Markets:企業の戦略・SWOT・財務情報
    Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report Summary Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • IHI Aerospace Co Ltd:企業の戦略・SWOT・財務情報
    IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report Summary IHI Aerospace Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Taishin International Bank Co Ltd:企業の戦略・SWOT・財務分析
    Taishin International Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taishin International Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines for heart diseases using stem cell-derived, patient-specific cardiac disease models. It also devel …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Holland Board of Public Works:企業の戦略的SWOT分析
    Holland Board of Public Works - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Sarepta Therapeutics Inc (SRPT):企業の財務・戦略的SWOT分析
    Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Olmsted Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes education, neurology, psychia …
  • Korn Ferry (KFY):企業の財務・戦略的SWOT分析
    Korn Ferry (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Engie SA (ENGI):石油・ガス:M&Aディール及び事業提携情報
    Summary Engie SA (Engie) is an electric utility. It provides electricity, natural gas, and energy services. It generates electricity from hydro, wind, biomass, and solar sources, and trades and sells that energy; supplies, distributes, trades, and sells natural gas; and offers a comprehensive range …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • mBio Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary MBio Diagnostics Inc (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from a …
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • ESSA Pharma Inc (EPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • Dyson Group Plc:企業の戦略的SWOT分析
    Dyson Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Ashapura Minechem Ltd.:企業の戦略・SWOT・財務分析
    Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ashapura Minechem Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Beth Israel Deaconess Medical Center Inc-製薬・医療分野:企業M&A・提携分析
    Summary Beth Israel Deaconess Medical Center Inc (BIDMC), a subsidiary of CareGroup Inc is a healthcare center that offers clinical care, biomedical research and education, health and wellness services. The center offers patient and family care services such as admitting, case management, ethics sup …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆